ES8501232A1 - Procedimiento para producir una formulacion topica estabilizada de acido seudomonico. - Google Patents
Procedimiento para producir una formulacion topica estabilizada de acido seudomonico.Info
- Publication number
- ES8501232A1 ES8501232A1 ES522677A ES522677A ES8501232A1 ES 8501232 A1 ES8501232 A1 ES 8501232A1 ES 522677 A ES522677 A ES 522677A ES 522677 A ES522677 A ES 522677A ES 8501232 A1 ES8501232 A1 ES 8501232A1
- Authority
- ES
- Spain
- Prior art keywords
- pref
- peg
- formulation
- deriv
- esp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 150000002148 esters Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- 239000002202 Polyethylene glycol Substances 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 abstract 1
- CTPDSKVQLSDPLC-UHFFFAOYSA-N 2-(oxolan-2-ylmethoxy)ethanol Chemical compound OCCOCC1CCCO1 CTPDSKVQLSDPLC-UHFFFAOYSA-N 0.000 abstract 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 abstract 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- -1 alkali metal salts Chemical class 0.000 abstract 1
- 125000005907 alkyl ester group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 208000032625 disorder of ear Diseases 0.000 abstract 1
- 208000030533 eye disease Diseases 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- MINDHVHHQZYEEK-HBBNESRFSA-N mupirocin Chemical compound C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-HBBNESRFSA-N 0.000 abstract 1
- 229960003128 mupirocin Drugs 0.000 abstract 1
- 229930194369 pseudomonic acid Natural products 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8215684 | 1982-05-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES522677A0 ES522677A0 (es) | 1984-12-01 |
| ES8501232A1 true ES8501232A1 (es) | 1984-12-01 |
Family
ID=10530708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES522677A Expired ES8501232A1 (es) | 1982-05-28 | 1983-05-24 | Procedimiento para producir una formulacion topica estabilizada de acido seudomonico. |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPS58219108A (enExample) |
| ES (1) | ES8501232A1 (enExample) |
| ZA (1) | ZA833692B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105555271A (zh) * | 2013-09-20 | 2016-05-04 | 参天制药株式会社 | 含有聚乙二醇的组合物 |
-
1983
- 1983-05-23 ZA ZA833692A patent/ZA833692B/xx unknown
- 1983-05-24 JP JP9139083A patent/JPS58219108A/ja active Granted
- 1983-05-24 ES ES522677A patent/ES8501232A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58219108A (ja) | 1983-12-20 |
| JPH0348886B2 (enExample) | 1991-07-25 |
| ZA833692B (en) | 1985-02-27 |
| ES522677A0 (es) | 1984-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE831205L (en) | Pharmaceutical formulations. | |
| UA41906C2 (uk) | Спосіб лікування неврологічних порушень, викликаних травмами | |
| AU549481B2 (en) | Hair growing agent | |
| TW234691B (enExample) | ||
| EP0285008A3 (en) | The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse | |
| CA2125662A1 (en) | Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis | |
| IT8323773U1 (it) | Mezzi di guida per l'estrazione di cassetti o simili | |
| ES8700850A1 (es) | 1,4-dihidropiridin-carboxiamidas. | |
| MY104006A (en) | 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases. | |
| ES8501232A1 (es) | Procedimiento para producir una formulacion topica estabilizada de acido seudomonico. | |
| LU90791I2 (fr) | Potentialisateur d'effets antineoplasique et agent antineoplasique | |
| IE56648B1 (en) | Polyether compounds | |
| GR78622B (enExample) | ||
| EP0471388A3 (de) | Mittel zur Behandlung der Herzinsuffizienz | |
| TW258733B (enExample) | ||
| GR81464B (enExample) | ||
| GR3035058T3 (en) | Use of derivatives of beta-naphthoquinone for inhibiting platelet aggregation. | |
| DE3168004D1 (en) | Ophthalmic composition of 5-fluoro-2-methyl-1-(p-methylthio-benzylidene)-3-indenylacetic acid or salt thereof | |
| IL86647A (en) | Pharmaceutical composition comprising 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid | |
| SE8303400D0 (sv) | Azo-bis-salicylsyra och salt derav samt deras farmaceutiska beredning och anvendning | |
| IT7945204A0 (it) | Composizione farmaceutica per la terapia delle sterilita' maschile | |
| MY110416A (en) | Composition for the treatment of schizophrenia. |